Haopeng Wang (@HaopengWang_Lab) header
Haopeng Wang (@HaopengWang_Lab) profile picture

Associate Professor at ShanghaiTech University & Adjunct Faculty Member at Institute for Immunology Tsinghua. Expertise in designing CAR-T, TCR-T, and CAR-Treg.

Shanghai, CHINA
Joined February 2023
Photo by Haopeng Wang (@HaopengWang_Lab)Photo by Haopeng Wang (@HaopengWang_Lab)Photo by Haopeng Wang (@HaopengWang_Lab)Photo by Haopeng Wang (@HaopengWang_Lab)Photo by Haopeng Wang (@HaopengWang_Lab)Photo by Haopeng Wang (@HaopengWang_Lab)Photo by Haopeng Wang (@HaopengWang_Lab)Photo by Haopeng Wang (@HaopengWang_Lab)Photo by Haopeng Wang (@HaopengWang_Lab)Photo by Haopeng Wang (@HaopengWang_Lab)
Beautiful Study from Dr. ZHUANG's lab!
PerCap isolates native peroxisomes to reveal peroxisomal proteins and regulators nature.com/articles/s41589-0…
1
1
58
Our study made the cover of @CellStemCell (Vol 33, Issue 8, 2026)! Cute🐸 Brown frogs (fulvestrant) recruit green frogs (iPhase-CAR) into growing droplets — a playful take on drug-induced CAR clustering at the T cell membrane. cell.com/cell-stem-cell/curr… #CARTcellTherapy
1
2
40
Haopeng Wang retweeted
『Anti-LAG-3 with or without anti-PD-1 in recurrent glioblastoma: a phase 1 trial』 Nature Medicine 10 July 2026 再発膠芽腫患者に対する抗LAG-3抗体 relatlimab の単独療法およびnivolumab併用療法を評価 インターフェロン応答が高く、T細胞クローン性の高い腫瘍では併用療法への反応が良好
3
6
567
Haopeng Wang retweeted
A warm welcome to Beijing, China on Aug 24–25, 2026 for "25 Years of Human Genome" – featuring ex-NHGRI Dir. Dr. Eric Green, NGS pioneer Dr. Jonathan Rothberg, NIPT inventor Dr. Dennis Lo & other top scientists. Agenda & Registration: sunneyxielab.org/25_years_of…
5
2
22
5,689
Haopeng Wang retweeted
Online Now! FDA-approved fulvestrant-induced CAR phase separation enables precise control of CAR T antitumor function dlvr.it/TTSDt7 #stemcells
6
8
1,463
Haopeng Wang retweeted
Online Now: T cell extracellular vesicles go nuclear to turn cold tumors hot dlvr.it/TSJd1y
33
1
80
5,905
Excited to share my Preview of David Lyden's elegant work in @Cancer_Cell: EVs deliver T cell genomic DNA into DCs & tumor cells. Combined with PD-1 blockade, cold tumors turn hot: A cell-free immunotherapy blueprint🔥 #CancerImmunotherapy #Immunology sciencedirect.com/science/ar…
1
1
48
Haopeng Wang retweeted
In the latest issue! Cell death in cancer dlvr.it/TS6BPY
33
1
123
10,127
Haopeng Wang retweeted
『Coordinated IL-2 and TGF-β Signaling via a Novel Fusion Protein Selectively Expands and Activates Regulatory T Cells』 bioRxiv March 11, 2026. CUE-401はIL-2とTGF-β3を組み合わせた二機能性バイオ医薬で、Tregを選択的誘導・増殖・安定化させ自己免疫反応を抑え動物モデルで免疫寛容達成
2
1
4
396
Our preview on the FIRST AAV-based in vivo CAR-T: No leukapheresis. No ex vivo manufacturing. Just inject. AI-engineered AAV selectively targets CD62L⁺ naive T cells → reverses SLE in humanized models 📖 vita-journal.com/vita/EN/10.… #InVivoCART #AAV #GeneTherapy #SLE
1
3
65
𝗥𝗲𝘁𝗵𝗶𝗻𝗸𝗶𝗻𝗴 𝗖𝗔𝗥-𝗧 𝗳𝗼𝗿 𝗔𝘂𝘁𝗼𝗶𝗺𝗺𝘂𝗻𝗲 𝗗𝗶𝘀𝗲𝗮𝘀𝗲: Our new study challenges the "transient depletion" paradigm: Genetic lupus needs persistent, not transient, CAR-T therapy. @JMCellBiol academic.oup.com/jmcb/advanc…
2
74
Haopeng Wang retweeted
Congratulations to Honggui, Jiankun, and Tan for improving the single-cell 3D genome resolution by a factor of 4 (to 5 Kb). This allowed direct visualization that multiple enhancers cluster to a particular gene promoter at the same time in a single cell. nature.com/articles/s41588-0…
5
22
1
79
5,874
Haopeng Wang retweeted
Congrats to Xinyao and Xie Chen! In eukaryotes, multiple transcription factors bind cooperatively to a regulatory region on genomic DNA to control gene expression. In this paper (bit.ly/3GV1BoP), we present an experimental metric for quantifying such cooperativity.
1
15
88
8,177
Understanding LAG3 immune checkpoint function nature.com/articles/d41573-0…
1
82